<?xml version="1.0" encoding="iso-8859-1"?>
<?xml-stylesheet type="text/xsl" href="http://www.physorg.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0">
<channel>
<title>PHYSorg.com: PHYSorg news tagged with: lymphatic</title>
<link>http://www.physorg.com/</link>
<language>en-us</language> 
<description>Physorg.com internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>New tools for prediction of disease progression in acute childhood leukemia</title>
   	 <description>(PhysOrg.com) -- Researchers at Uppsala University and University Children`s Hospital in Uppsala have devised powerful new tools for typing cells from children with acute lymphatic leukemia and for prediction of how children with leukemia will respond to chemotherapy. The study was recently published in electronic form by the prestigious hematological journal Blood.</description>
     <link>http://www.physorg.com/news178550370.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 27 Nov 2009 13:21:30 EST</pubDate>
	 <guid isPermaLink="false">news178550370</guid>
</item>
<item>
     <title>Discovery offers potential new pancreatic cancer treatment</title>
   	 <description>Tiny particles that can carry drugs and target cancer cells may offer treatment hope for those suffering with pancreatic cancer.  New research to be presented in November at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Los Angeles reveals that tumor-penetrating microparticles (TPM) have been specifically designed to break through hard-to-infiltrate barriers and deliver drugs more effectively and efficiently than the standard form of chemotherapy such as those injected through a vein.</description>
     <link>http://www.physorg.com/news176392083.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 02 Nov 2009 14:20:01 EST</pubDate>
	 <guid isPermaLink="false">news176392083</guid>
</item>
<item>
     <title>Nanoparticles Detect and Purge Metastases in Lymph Nodes</title>
   	 <description>Colonoscopy represents one of the great weapons against cancer. In one step, a physician can find precancerous lesions in the colon and then cut them out, an on-the-spot intervention that prevents cancer from developing. Now, researchers at the Winthrop Rockefeller Cancer Institute and the University of Arkansas for Medical Sciences have developed another fiber optic technique that can detect lymph node metastases and destroy them on the spot, an action that could prevent the further spread of breast cancer, melanoma, or gastrointestinal cancer, all of which spread through the lymphatic system.</description>
     <link>http://www.physorg.com/news176116481.html</link>
	 <category>Nanotechnology</category>
	 <pubDate>Fri, 30 Oct 2009 10:15:06 EST</pubDate>
	 <guid isPermaLink="false">news176116481</guid>
</item>
<item>
     <title>Surveys for major neglected tropical diseases in sub-Saharan Africa can be integrated</title>
   	 <description>It is possible to simultaneously survey a number of neglected tropical diseases (NTDs) in the challenging environment of Southern Sudan, according to a new study published October 27 in the open-access journal PLoS Neglected Tropical Diseases. The research, coordinated by Malaria Consortium Africa on behalf of the government of Southern Sudan, rapidly identified areas requiring mass treatment for schistosomiasis and intestinal worm infections, and showed that two diseases, lymphatic filariasis and loiasis, were not endemic in Northern Bahr-el-Ghazal State, an area the size of Belgium.</description>
     <link>http://www.physorg.com/news175842633.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 27 Oct 2009 06:11:05 EST</pubDate>
	 <guid isPermaLink="false">news175842633</guid>
</item>
<item>
     <title>Physical therapists play integral role in prevention, risk reduction, and treatment of lymphedema</title>
   	 <description>As breast cancer awareness month is observed during October, the American Physical Therapy Association (APTA) is hoping to shine a spotlight on lymphedema, a chronic, debilitating and often irreversible side effect of cancer treatment.</description>
     <link>http://www.physorg.com/news174846489.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 15 Oct 2009 17:28:54 EST</pubDate>
	 <guid isPermaLink="false">news174846489</guid>
</item>
<item>
     <title>Researchers discover novel circulation in human eye, new glaucoma treatment target</title>
   	 <description>Researchers at the University of Toronto, St. Michael's Hospital and Sunnybrook Health Sciences Centre have discovered a previously unidentified form of circulation within the human eye which may provide important new insights into glaucoma, a leading cause of blindness.</description>
     <link>http://www.physorg.com/news173966488.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 05 Oct 2009 13:30:02 EST</pubDate>
	 <guid isPermaLink="false">news173966488</guid>
</item>
<item>
     <title>Parasite bacteria may help fight spread of mosquito-borne diseases</title>
   	 <description>Infecting mosquitoes with a bacterial parasite could help prevent the spread of lymphatic filariasis, one of the major neglected tropical diseases of the developing world, according to research published today in the journal Science.</description>
     <link>http://www.physorg.com/news173627112.html</link>
	 <category>Biology</category>
	 <pubDate>Thu, 01 Oct 2009 15:30:01 EST</pubDate>
	 <guid isPermaLink="false">news173627112</guid>
</item>
<item>
     <title>Golden Nanotubes Detect Tumor Cells, Map Sentinel Lymph Nodes</title>
   	 <description>(PhysOrg.com) -- Biomedical researchers at the University of Arkansas in Fayetteville and the University of Arkansas for Medical Sciences (UAMS) in Little Rock have developed a special contrast-imaging agent made of gold-coated carbon nanotubes that is capable of molecular mapping of lymphatic endothelial cells and detecting cancer metastasis in sentinel lymph nodes. The findings from this study, which was led by Jin-Woo Kim, Ph.D., M.S., University of Arkansas, and Vladimir P. Zharov, Ph.D., D.Sc., M.S., UAMS, were published in the journal Nature Nanotechnology. </description>
     <link>http://www.physorg.com/news172951791.html</link>
	 <category>Nanotechnology</category>
	 <pubDate>Thu, 24 Sep 2009 17:10:01 EST</pubDate>
	 <guid isPermaLink="false">news172951791</guid>
</item>
<item>
     <title>New discovery brings hope to treatment of lymphatic diseases</title>
   	 <description>Researchers in the laboratory of Dr. Jayakrishna Ambati at the University of Kentucky have discovered the first naturally occurring molecule that selectively blocks lymphatic vessel growth. In an article in the Aug. 9, 2009 online edition of Nature Medicine, they report the identification of a new molecule known as soluble VEGFR-2 that blocks lymphangiogenesis - the growth of lymphatics - but not blood vessel growth.</description>
     <link>http://www.physorg.com/news169124797.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 10 Aug 2009 12:07:08 EST</pubDate>
	 <guid isPermaLink="false">news169124797</guid>
</item>
<item>
     <title>Building the lymphatic drainage system</title>
   	 <description>Our bodies' tissues need continuous irrigation and drainage. Blood vessels feeding the tissues bring in the fluids, and drainage occurs via the lymphatic system. While much is known about how blood vessels are built, the same was not true for lymph vessels. Now though, Norrm&amp;eacute;n et al. have identified two of the lead engineers that direct drainage construction in the mouse embryo.</description>
     <link>http://www.physorg.com/news160028799.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 27 Apr 2009 05:26:59 EST</pubDate>
	 <guid isPermaLink="false">news160028799</guid>
</item>
<item>
     <title>Side effects of 'gene-silencing' treatment more wide-ranging than previously thought</title>
   	 <description>The side effects of an experimental "gene-silencing" treatment that is currently being investigated for a variety of diseases are even more wide-ranging than previously discovered, according to a study by a University of Kentucky researcher.</description>
     <link>http://www.physorg.com/news158257334.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 06 Apr 2009 17:22:36 EST</pubDate>
	 <guid isPermaLink="false">news158257334</guid>
</item>
<item>
     <title>Reprogrammable cell type depends on a single gene to keep its identity</title>
   	 <description>Scientists at St. Jude Children's Research Hospital have discovered that a certain differentiated cell type is so ready to change its identity that it requires the constant expression of a gene called Prox1 to dissuade it.</description>
     <link>http://www.physorg.com/news147357294.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Dec 2008 12:34:54 EST</pubDate>
	 <guid isPermaLink="false">news147357294</guid>
</item>
<item>
     <title>Knocking the Sox off cancer and lymphatic disorders</title>
   	 <description>(PhysOrg.com) -- Researchers have identified a gene critical for the development of the lymphatic system in a discovery that will have implications for treatment of cancer and lymphatic disorders and other diseases.</description>
     <link>http://www.physorg.com/news143709300.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Oct 2008 08:15:00 EST</pubDate>
	 <guid isPermaLink="false">news143709300</guid>
</item>
<item>
     <title>Study suggests LF elimination program is 'best buy in public health'</title>
   	 <description>A study published today concludes that in the ten years since its initiation, the international effort to eliminate lymphatic filariasis (LF) has made a large impact towards ridding the world of one of its most debilitating diseases.  The analysis found that the LF elimination programme has prevented 6.6 million children from acquiring LF and stopped another 9.5 million people already infected with the disease from progressing to more debilitating stages.  These efforts are the result of the most rapid scale-up of a drug administration programme in public health history, delivering what the study calls a "best buy in public health".</description>
     <link>http://www.physorg.com/news142656435.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 08 Oct 2008 03:47:15 EST</pubDate>
	 <guid isPermaLink="false">news142656435</guid>
</item>


</channel>
</rss>

